Analystreport

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its price target lowered by analysts at Roth Capital from $185.00 to $175.00.

Ligand Pharmaceuticals Incorporated  (LGND) 
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.ligand.com